These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8709132)

  • 21. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
    Gao ZG; Kim SG; Soltysiak KA; Melman N; IJzerman AP; Jacobson KA
    Mol Pharmacol; 2002 Jul; 62(1):81-9. PubMed ID: 12065758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.
    Jacobson KA; Park KS; Jiang JL; Kim YC; Olah ME; Stiles GL; Ji XD
    Neuropharmacology; 1997 Sep; 36(9):1157-65. PubMed ID: 9364471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.
    Baraldi PG; Cacciari B; Pineda de Las Infantas MJ; Romagnoli R; Spalluto G; Volpini R; Costanzi S; Vittori S; Cristalli G; Melman N; Park KS; Ji XD; Jacobson KA
    J Med Chem; 1998 Aug; 41(17):3174-85. PubMed ID: 9703463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
    Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
    Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
    Shearman LP; Weaver DR
    Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
    Olah ME; Gallo-Rodriguez C; Jacobson KA; Stiles GL
    Mol Pharmacol; 1994 May; 45(5):978-82. PubMed ID: 8190112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyran Template Approach to the Design of Novel A
    Li AH; Ji XD; Kim HS; Melman N; Jacobson KA
    Drug Dev Res; 1999 Dec; 48(4):171-177. PubMed ID: 27182099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
    Palmer TM; Poucher SM; Jacobson KA; Stiles GL
    Mol Pharmacol; 1995 Dec; 48(6):970-4. PubMed ID: 8848012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
    van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
    Prentice DJ; Hourani SM
    Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.
    Poucher SM; Keddie JR; Singh P; Stoggall SM; Caulkett PW; Jones G; Coll MG
    Br J Pharmacol; 1995 Jul; 115(6):1096-102. PubMed ID: 7582508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KW-3902, a selective high affinity antagonist for adenosine A1 receptors.
    Nonaka H; Ichimura M; Takeda M; Kanda T; Shimada J; Suzuki F; Kase H
    Br J Pharmacol; 1996 Apr; 117(8):1645-52. PubMed ID: 8732272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.